Kara Murphy
Partner,
Profilo di Kara
Competenze
Kara Murphy is a member of Bain's Private Equity and Healthcare & Life Sciences practices and co-leads the firm's healthcare private equity team. She has worked at Bain since 2000.
She has led more than 175 healthcare private equity diligences and has worked extensively with private-equity backed portfolio companies. Her private equity work spans the healthcare value chain of med tech, pharma, providers, payers, services and IT.
Kara also has worked with corporate clients across the healthcare value chain on issues ranging from M&A to growth strategy to performance improvement.
Kara earned her MBA from Harvard Business School. She is also a graduate of Tufts University, where she received a Bachelor of Science in mathematics and quantitative economics.
Kara Murphy discusses how private equity and corporate investors can evaluate business opportunities and risks that these trends create.
Recent Insights
- “Healthcare Private Equity Market 2022: The Year in Review and Outlook,” Report, gennaio 2023
- “Healthcare Private Equity in a Downturn,” Report, gennaio 2023
- “Life Sciences: White-Hot Competition to Win the Right Deals,” Report, gennaio 2023
- “Welcome Letter: Sizing Up the Great Adaptation,” Report, marzo 2022
- “Healthcare Private Equity Market 2021: The Year in Review ,” Report, marzo 2022
In the News
- “Healthcare private equity market shows resilience with second strongest year on record, despite economic and geopolitical disruptions—preview of Bain & Company analysis,” Press release, gennaio 2023
- “Megadeals are here to stay, and they’re redefining the healthcare landscape,” Press release, marzo 2022
- “Healthcare private equity buyouts posted record-setting volumes in 2020 after a year of unprecedented upheaval for global healthcare,” Press release, marzo 2021
- “HCIT M&A in the wake of COVID-19; Blackstone goes shopping,” PE Hub, marzo 2020, Sanità
- “Column: Bain's Kara Murphy on the Amazon Effect, provider deal flow ,” Buyouts, aprile 2018, Sanità